Windmill Cardiovascular Systems
Texas-based Windmill Cardiovascular Systems, Inc. manufactures smart LVADs for heart failure treatment.
Founded
2005Texas-based Windmill Cardiovascular Systems, Inc. manufactures smart LVADs for heart failure treatment.
Windmill Cardiovascular Systems, Inc., founded in 2005 and based in Austin, Texas, focuses on developing advanced left ventricular assist devices (LVADs) for heart failure treatment. The company's core mission is to enhance patient outcomes through innovative technology that provides synchronized pulsatile ejections, addressing issues found in continuous flow devices. Their flagship product, the TORVAD platform, aims to improve patient care with gentle blood handling and pulsatile flow, targeting the heart failure market.
Notable figures affiliated with Windmill Cardiovascular Systems include a team of experienced scientific advisors and industry experts. The company has achieved significant milestones in the development of its LVAD technology, positioning itself as a leader in the cardiovascular device industry. By addressing critical challenges in heart failure treatment, Windmill Cardiovascular Systems has made a substantial impact on improving patient quality of life and advancing medical technology.
Companies similar to Windmill Cardiovascular Systems include Evaheart, NuPulseCV, Reprieve Cardiovascular and Vadovations.
Windmill Cardiovascular Systems was founded in 2005.
Windmill Cardiovascular Systems' headquarters is located in Austin, TX, US.
Windmill Cardiovascular Systems' most recent funding round was for $420k (USD) in September 2012.
As of Sep 11, 2012, Windmill Cardiovascular Systems has disclosed funding of $920k (USD). Undisclosed round amounts are excluded.
Windmill Cardiovascular Systems has 8 employees as of Feb 5, 2024.
Vadovations
